Detalles de la búsqueda
1.
Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study.
BMC Infect Dis
; 17(1): 420, 2017 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-28610605
2.
Early detection of chronic hepatitis B and risk factor assessment in Turkish migrants, Middle Limburg, Belgium.
PLoS One
; 15(7): e0234740, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32716949
3.
Hepatitis B virus prevalence and risk factors in hard-to-reach Turkish population living in Belgium: A protocol for screening.
Medicine (Baltimore)
; 98(18): e15412, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31045797
4.
Early prediction of major depression in chronic hepatitis C patients during peg-interferon alpha-2b treatment by assessment of vegetative-depressive symptoms after four weeks.
World J Gastroenterol
; 13(43): 5736-40, 2007 Nov 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-17963300
5.
Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study.
Int J Drug Policy
; 47: 230-238, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28633998
6.
Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study.
Int J Drug Policy
; 47: 177-186, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28624134
Resultados
1 -
6
de 6
1
Próxima >
>>